Goldline Pharmaceutical Ltd PE Ratio

Goldline Pharmaceutical PE Ratio

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

PE

-

Last updated on: Jun 14, 2026

Key Highlights

  • The P/E Ratio of Goldline Pharmaceutical Ltd is 0 as of 14 Jun 9.00 AM The P/E Ratio of Goldline Pharmaceutical Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years The Latest Trading Price of Goldline Pharmaceutical Ltd is ₹ 46.55 as of 12 Jun 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60% The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 28.4. The PE Ratio of IT - Software industry is 18.2. The PE Ratio of Pharmaceuticals industry is 42.6. The PE Ratio of Retail industry is 67.8. The PE Ratio of Textiles industry is 23.9 in 2025 .

Historical P/E Ratio of Goldline Pharmaceutical Ltd

No data available

Company Fundamentals for Goldline Pharmaceutical Ltd

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

Share Price

₹ 46.55

-1.50 (-3.12%)

stock direction

Last updated on: Jun 12, 2026

Market Price of Goldline Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Jun 202646.55
11 Jun 202648.05
10 Jun 202648.95
09 Jun 202643.15
08 Jun 202644.2
05 Jun 202645.25
04 Jun 202642.96
03 Jun 202642.96
02 Jun 202643.97
01 Jun 202646.03

BlinkX Score for Goldline Pharmaceutical Ltd

Asset Value vs Market Value of Goldline Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Goldline Pharmaceutical Ltd44.69
Sun Pharmaceutical Industries Ltd433620
Divis Laboratories Ltd176087
Torrent Pharmaceuticals Ltd154837
Cipla Ltd112194
Zydus Lifesciences Ltd111123

PE Ratio of Goldline Pharmaceutical Ltd Explained

44.69

Market cap

2

Earnings

0.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Goldline Pharmaceutical Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Goldline Pharmaceutical Ltd

No data available

* All values are in %

About Goldline Pharmaceutical Ltd

  • Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
  • Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
  • September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
  • Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
  • The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.

Goldline Pharmaceutical Ltd News Hub

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc

Read more

19 May 26

Goldline Pharmaceutical to discuss results

Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.

Read more

03 Jun 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Goldline Pharmaceutical Ltd

What is the current PE Ratio of Goldline Pharmaceutical Ltd?

The Current PE Ratio of Goldline Pharmaceutical Ltd is 0.0 as on 14 Jun 2026.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 42.6 as on 14 Jun 2026.

What was the PE Ratio of Goldline Pharmaceutical Ltd last year?

The PE Ratio of Goldline Pharmaceutical Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Goldline Pharmaceutical Ltd indicate about its stock?

The PE Ratio of Goldline Pharmaceutical Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Goldline Pharmaceutical Ltd.

What is the PE Ratio Growth of Goldline Pharmaceutical Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Goldline Pharmaceutical Ltd grew by -% whereas, the EPS ratio grew by 118.0.

How does the PE ratio of Goldline Pharmaceutical Ltd compare to industry peers?

The PE ratio of Goldline Pharmaceutical Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Goldline Pharmaceutical Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Goldline Pharmaceutical Ltd PE Ratio.

What factors influence the PE ratio of Goldline Pharmaceutical Ltd PE Ratio?

The PE ratio of Goldline Pharmaceutical Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Goldline Pharmaceutical Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Goldline Pharmaceutical Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Goldline Pharmaceutical Ltd PE Ratio?

You can check the latest PE ratio of Goldline Pharmaceutical Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Goldline Pharmaceutical Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Goldline Pharmaceutical Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Goldline Pharmaceutical Ltd PE Ratio predict future stock performance?

While the Goldline Pharmaceutical Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions